The use of immunomodulators in the control of infectious bovine rhinotracheitis.
Three experiments have been carried out to verify the effectiveness of an immunomodulator, Baypamun (Bayer AG) in limiting the spread of Bovine herpesvirus-1 (BHV-1), the causal agent of infectious bovine rhinotracheitis (IBR). In the first experiment, four calves infected with BHV-1 developed severe disease whereas four calves given Baypamun simultaneously with the virus had less severe disease. Four other calves in contact with the infected calves became severely ill but another four given Baypamun were only mildly affected. In the second experiment three calves infected with BHV-1, which reacted with typical disease, were allowed to remain in contact with six calves. All six calves were given Baypamun at various times following the exposure to BHV-1 infection and all showed a much reduced reaction with two treated for 4 days developing no clinical disease. Finally, in the third experiment one calf vaccinated one month before the start of the experiment did not develop any signs of disease when housed together with a calf experimentally infected with BHV-1. Of four other calves, vaccinated when the infected calf showed the first signs of disease, only the two given Baypamun in addition to the vaccine, were protected from clinical disease whereas the two given vaccine only developed classical signs of IBR. In the three experiments the virus shedding by the Baypamun-treated calves resulted to be significantly reduced.
Castrucci
G
G
Istituto di Malattie Infettive, Laboratorio di Virologia, V. Cilli, Facoltà di Medicina Veterinaria, Perugia, Italy.
Osburn
B I
BI
Frigeri
F
F
Ferrari
M
M
Salvatori
D
D
Lo Dico
M
M
Barreca
F
F
D000276:Adjuvants, Immunologic / Q000627:therapeutic use*; D000818:Animals; D000914:Antibodies, Viral / Q000097:blood; D002417:Cattle; D007241:Infectious Bovine Rhinotracheitis / Q000517:prevention & control*; D009500:Neutralization Tests; D014765:Viral Vaccines / Q000627:therapeutic use*; D017201:Virus Shedding
D000276:Adjuvants, Immunologic; D000914:Antibodies, Viral; C076692:Baypamun HK; D014765:Viral Vaccines